Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.50 |
| ▸ | GAA | P10253 | 4/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | GLA | P06280 | 2/20 | 0.50 |
| ▸ | HTT | P42858 | 2/20 | 0.50 |
| ▸ | S100A4 | P26447 | 1/20 | 0.50 |
| ▸ | HPGD | P15428 | 1/20 | 0.50 |
| ▸ | ATM | Q13315 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | PARP1 | P09874 | 8/20 | 0.46 |
| ▸ | MEN1 | O00255 | 3/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.46 |
| ▸ | TNKS | O95271 | 2/20 | 0.46 |
| ▸ | PARP15 | Q460N3 | 2/20 | 0.46 |
| ▸ | TNKS2 | Q9H2K2 | 2/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | GPR3 | P46089 | 1/20 | 0.46 |
| ▸ | BLM | P54132 | 1/20 | 0.46 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29441228 | 0.84 | ALDH1A1 (0.50) | KDM4EGAAALDH1A1LMNAGLA | |
| SCHEMBL796579 | 0.84 | ALDH1A1 (0.50) | KDM4EGAAALDH1A1LMNAGLA | |
| SCHEMBL10018672 | 0.79 | ALDH1A1 (0.46) | KDM4EGAAALDH1A1LMNAGLA | |
| SCHEMBL30019304 | 0.79 | ALDH1A1 (0.46) | KDM4EGAAALDH1A1LMNAGLA | |
| SCHEMBL2788682 | 0.79 | ALDH1A1 (0.46) | KDM4EGAAALDH1A1LMNAGLA | |
| SCHEMBL29895470 | 0.79 | ALDH1A1 (0.46) | KDM4EGAAALDH1A1LMNAGLA | |
| SCHEMBL11325702 | 0.79 | SRC (0.46) | KDM4EGAAALDH1A1LMNAHPGD | |
| SCHEMBL342450 | 0.79 | SRC (0.46) | KDM4EGAAALDH1A1LMNAHPGD | |
| SCHEMBL3081936 | 0.76 | PARP1 (0.71) | KDM4EGAAALDH1A1LMNAGLA | |
| SCHEMBL17792659 | 0.76 | SRC (0.50) | KDM4EGAAALDH1A1LMNAHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110149128-A1 | Anthraquinone dye-containing material, composition including the same, camera including the same, and associated methods | CHIEL INDUSTRIES, INC. (KR) | 2011-06-23 | — | — | US | claimed |
| US-8492569-B2 | Anthraquinone dye-containing material, composition including the same, camera including the same, and associated methods | CHEIL INDUSTRIES, INC. (KR) | 2013-07-23 | — | — | US | disclosed |
| US-20110149128-A1 | Anthraquinone dye-containing material, composition including the same, camera including the same, and associated methods | CHIEL INDUSTRIES, INC. (KR) | 2011-06-23 | — | — | US | disclosed |
| EP-1655017-B1 | Use of compounds of the type organosilane for dyeing keratinic fibres | OREAL (FR) | 2009-12-30 | — | — | EP | disclosed |
| US-7354459-B2 | Use of organosilane compounds for dyeing keratin fibers | L'OREAL S.A. (FR) | 2008-04-08 | — | — | US | disclosed |
| US-20060112500-A1 | Use of organosilane compounds for dyeing keratin fibers | L'OREAL S.A. (FR) | 2006-06-01 | — | — | US | disclosed |
| EP-1655017-A1 | Use of compounds of the type organosilane for dyeing keratinic fibres | L'OREAL (FR) | 2006-05-10 | — | — | EP | disclosed |
| EP-1341676-B1 | DONOR ELEMENT FOR ADJUSTING THE FOCUS OF AN IMAGING LASER | DU PONT (US) | 2006-04-19 | — | — | EP | disclosed |
| US-6958202-B2 | Donor element for adjusting the focus of an imaging laser | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2005-10-25 | — | — | US | disclosed |
| EP-1341675-B1 | BACKING LAYER OF A DONOR ELEMENT FOR ADJUSTING THE FOCUS ON AN IMAGING LASER | DU PONT (US) | 2005-04-27 | — | — | EP | disclosed |
| EP-1341675-A1 | BACKING LAYER OF A DONOR ELEMENT FOR ADJUSTING THE FOCUS ON AN IMAGING LASER | E.I. DUPONT DE NEMOURS AND COMPANY (US) | 2003-09-10 | — | — | EP | disclosed |
| EP-1341676-A1 | DONOR ELEMENT FOR ADJUSTING THE FOCUS OF AN IMAGING LASER | E. I. du Pont de Nemours and Company (US) | 2003-09-10 | — | — | EP | disclosed |
| EP-1341672-A2 | RECEIVER ELEMENT FOR ADJUSTING THE FOCUS OF AN IMAGING LASER | E. I. du Pont de Nemours and Company (US) | 2003-09-10 | — | — | EP | disclosed |
| WO-2002047919-A1 | BACKING LAYER OF A DONOR ELEMENT FOR ADJUSTING THE FOCUS ON AN IMAGING LASER | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2002-06-20 | — | — | WO | disclosed |
| WO-2002047917-A2 | RECEIVER ELEMENT FOR ADJUSTING THE FOCUS OF AN IMAGING LASER | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2002-06-20 | — | — | WO | disclosed |
| WO-2002047918-A1 | DONOR ELEMENT FOR ADJUSTING THE FOCUS OF AN IMAGING LASER | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2002-06-20 | — | — | WO | disclosed |
| US-6210783-B1 | COMPRISED OF SUPPORTING SUBSTRATE, A HEAT DISSIPATING COATING LAYER IN CONTACT WITH SUBSTRATE, WHEREIN COATING IS COMPRISED OF A HEAT DISSIPATING BINDER, AN ANTISTATIC COMPOUND, AN INK RECEIVER COATING COMPRISING BINDER, OXAZOLINE COMPOUND | XEROX CORPORATION | 2001-04-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060112500-A1 | Use of organosilane compounds for dyeing keratin fibers | KRT18, TUBB6, TUBB1 | KDM4E 1281/4885GAA 3580/4885ALDH1A1 124/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.